Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation

NCT01283776 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Non-Hodgkin-Lymphoma
Hodgkin's Disease

Interventions

DRUG: Cyclophosphamide

Sponsor

University of Cologne